ARTS Biologics A/S
The idea to found ARTS Biologics was conceived in December 2010 by Svend Lindenberg, David Kauffmann and Peter Nordkild. ARTS Biologics was founded over the summer 2011 by Svend Lindenberg, David Kauffmann, Kim Vilbour Andersen, Kim Ry Hejnæs, Claus Yding Andersen, Hans Schambye and Peter Nordkild.
ARTS Biologics is focusing on developing a range of improved gonadotrophins to facilitate modern assisted reproductive therapy with single embryo transfer and lower side effects.
ARTS Biologics is funded by the founders, Novozymes A/S and a few family offices. The company aim to have proof of concept in animals over the summer 2012.